Info

Anesiva, Inc. (Anesiva) is a biopharmaceutical company focused on the development and commercialization of therapeutic treatments for pain management. Its portfolio of products includes Zingo powder intradermal injection system, which was approved by the United States Food and Drug Administration (FDA) in August 2007, and Adlea, which is a long-acting, site-specific, non-opioid analgesic, being developed for moderate to severe pain, and has completed multiple Phase II trials in post-surgical, musculoskeletal and neuropathic pain. In October 2007, it announced that its Phase III clinical trial in adults requested by FDA met its primary endpoint.(Source: 10-K)